Hypertension Management in Cancer Patients
Hypertension Management in Cancer Patients: Bringing PCPs Back Into Cancer Care
Sponsor: Duke Institute for Health Innovation
Terminated
Initially suspended due to Covid-19. After much consideration, it was determined that we do not have the bandwidth to resume recruitment or any activities for this project.
Other Blood Pressure trials with similar outcome
Listed as NCT03919214, this NA trial focuses on Blood Pressure and CLL and remains terminated or withdrawn. Sponsored by Duke Institute for Health Innovation, it has been updated 15 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2023 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Feb 2022 — May 2023 [monthly]
Suspended NA
-
Feb 2021 — Feb 2022 [monthly]
Suspended NA
▶ Show 10 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Suspended NA
-
Oct 2020 — Jan 2021 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2020 — Oct 2020 [monthly]
Recruiting NA
-
Jan 2020 — Jun 2020 [monthly]
Recruiting NA
-
Dec 2019 — Jan 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting NA
-
Aug 2019 — Oct 2019 [monthly]
Not Yet Recruiting NA
-
Jul 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
-
May 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke Institute for Health Innovation
- Duke University
For direct contact, visit the study record on ClinicalTrials.gov .